Z Gastroenterol 2018; 56(01): E2-E89
DOI: 10.1055/s-0037-1612755
Poster Visit Session III Metabolism and Transport – Friday, January 26, 2018, 4:30pm – 5:15pm, Foyer area East Wing
Georg Thieme Verlag KG Stuttgart · New York

Change in hepatic iron metabolism in a rat model of acute liver damage and recovery: a role for iron storage proteins

I Malik
1   University Medical Center, Institute of Anatomy and Cell Biology, Göttingen
,
J Wilting
1   University Medical Center, Institute of Anatomy and Cell Biology, Göttingen
,
G Ramadori
2   University Medical Center, Göttingen
,
N Naz
2   University Medical Center, Göttingen
› Author Affiliations
Further Information

Publication History

Publication Date:
03 January 2018 (online)

 

Question:

Study iron metabolism in liver, spleen, and serum after acute liver-damage, in relation to surrogate markers for liver-damage and repair.

Methods:

Rats received intraperitoneal injection of the hepatotoxin thioacetamide (TAA), and were sacrificed regularly between 1 and 96 hours (h) thereafter. Serum levels of transaminases and iron were measured using conventional laboratory assays. Liver tissue was used for conventional histology, immunohistology, and iron staining. The expression of acute-phase cytokines, ferritin light chain (FTL), and ferritin heavy chain (FTH) was investigated in the liver by qRT-PCR. Western blotting was used to investigate FTL and FTH in liver tissue and serum. Liver and spleen tissue was also used to determine iron concentrations.

Results:

After a short initial decrease, iron serum concentrations increased in parallel with serum transaminase (ALT and AST) levels, which reached a maximum at 48h, and decreased thereafter. Similarly, after 48h a significant increase in FTL, and after 72h in FTH was detected in serum. While earliest morphological signs of inflammation in liver were visible after 6h, increased expression of the two acute-phase cytokines IFN-γ (1h) and IL-1β (3h) was detectable earlier, with maximum values after 12 – 24h. Iron concentrations in liver tissue increased steadily between 1h and 48h, and remained high at 96h. In contrast, spleen iron concentrations remained unchanged until 48h, and increased mildly thereafter (96h). Although tissue iron staining was negative, hepatic FTL and FTH protein levels were strongly elevated. Our results reveal effects on hepatic iron concentrations after direct liver injury by TAA. The increase of liver iron concentrations may be due to the uptake of a significant proportion of the metal by healthy hepatocytes, and only to a minor extent by macrophages, as spleen iron concentrations do not increase in parallel. The temporary increase of iron, FTH and transaminases in serum is obviously due to their release by damaged hepatocytes.

Conclusion:

Increased liver iron levels may be the consequence of hepatocyte damage. Iron released into serum by damaged hepatocytes is obviously transported back and stored via ferritins.